Alper Öner

Alper Öner

Interventional cardiologist / Cardiologist
Klinikum Leverkusen - Leverkusen, Germany

Latest contributions

Challenges for TAVI in bicuspid

22 May 2026 – From EuroPCR 2026

This session addresses the unique challenges encountered during transcatheter aortic valve implantation (TAVI) in patients with bicuspid aortic valves. It covers procedural nuances for type 0 bicuspid valves, risks associated with anomalous coronary anatomy, and complex anatomical considerations such as large annulus and tortuous aorta, culminating...

Getting it right the first time: Optimising the index TAVI for durable outcomes in young and intermediate / Low-risk patients

28 Apr 2026

Join A. Öner, D. Buckert and A. Khokhar as they explore multidisciplinary decision-making, lifetime management in low and intermediate-risk TAVI patients.

The future of aortic valve replacement - From index procedure to lifetime management

28 Apr 2026

A 68-year-old woman presents with symptomatic aortic stenosis and tricuspid valve anatomy, with no significant comorbidities and no evidence of coronary artery disease. Given her strong preference for a less invasive strategy, the Heart Team considers a transcatheter approach.
How would you treat this patient—and in case...

Dominik Buckert

Author

Dominik Buckert

Author

Alper Öner
Arif Khokhar

Author

Arif Khokhar

TAVI Essentials: From patient selection to procedural success

20 Mar 2026

Led by Ole De Backer, Christian Frerker and Alper Öner: a comprehensive expert-driven report covering the state of the art in aortic stenosis treatment.

Revisiting aortic valve replacement in light of the new ESC/EACTS guidelines

04 Mar 2026

Dive into a webinar uncovering how cardiac CT is transforming the evaluation and lifetime management of severe aortic stenosis—from sharper diagnostics to smarter valve choices.

Interdisciplinary therapeutic strategy in a low-risk patient with aortic stenosis and preserved life expectancy

05 Mar 2026

A 71-year-old low-risk patient with symptomatic severe aortic stenosis and preserved ventricular function presents with progressive dyspnoea and chest pain. With long life expectancy, the choice of treatment demands careful interdisciplinary planning. How would you treat?

Conradi Lenard

Author

Lenard Conradi

Author

Ole De Backer

Author

Alper Öner
Thomas Pilgrim

Author

Thomas Pilgrim

The index valve matters: optimal index TAVI for a lifetime of possibilities

18 Nov 2025 – From PCR London Valves 2025

Discover how thoughtful index valve selection and implantation techniques can shape the long-term management of patients undergoing TAVI. This PCR London Valves 2025 session highlights treatment considerations for low- and intermediate-risk patients, explores how valve choice affects the feasibility of future interventions, and examines strategies to...

The index valve matters: optimal index TAVI for a lifetime of possibilities

Just CINCH - Indirect annuloplasty for secondary mitral regurgitation in heart failure patients

16 Nov 2025 – From PCR London Valves 2025

This session provides a detailed review of indirect annuloplasty as an interventional treatment for secondary mitral regurgitation in heart failure patients, with a focus on the landmark EMPOWER trial. Learn about patient selection optimisation, procedural considerations involving the coronary sinus and left circumflex artery, and future...

Just CINCH - Indirect annuloplasty for secondary mitral regurgitation in heart failure patients

Self-expanding intra-annular TAVI in small annulus

16 Dec 2024

How would you treat this 76-year-old female patient presenting with significant dyspnea (NYHA III), a history of CAD, and recent NSTEMI with stenting of the RCA? On examination, she has a systolic heart murmur, and TTE reveals severe aortic stenosis with mild regurgitation, along with severe left...

Author

Samuel Lee